WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in OGN — Organon & Co.

CIK 1632972 PLYMOUTH, MN

Back to OGN Full portfolio

Position in OGN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$381,719

+$112,457 QoQ

Shares Held

28,192

-37.3% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#204

of 626 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $1,542,735,587 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,833,813	$465,733,487
2	LLY	ELI LILLY & Co	183,702	$220,337,708
3	MRK	Merck & Co., Inc.	1,625,531	$208,880,733
4	AMGN	Amgen Inc	464,220	$168,103,346
5	ABBV	AbbVie Inc.	576,543	$145,081,280
6	BMY	Bristol Myers Squibb Co	1,764,695	$101,681,725
7	GILD	Gilead Sciences, Inc.	603,836	$76,288,640
8	PFE	Pfizer Inc	3,158,575	$76,058,486

All Filings in OGN

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$381,719	28,192	-37.3%	Shares	Sole	2026-07-15
2026-03-31	$269,262	44,952	-41.3%	Shares	Sole	2026-04-08
2025-12-31	$548,841	76,547	-27.4%	Shares	Sole	2026-01-08
2025-09-30	$1,125,960	105,427	+87.9%	Shares	Sole	2025-10-29
2025-06-30	$543,164	56,112	+57.6%	Shares	Sole	2025-07-10
2025-03-31	$530,158	35,605	-16.9%	Shares	Sole	2025-04-16
2024-09-30	$819,911	42,860	-5.6%	Shares	Sole	2024-10-24
2024-06-30	$939,904	45,406	+17.4%	Shares	Sole	2024-07-16
2024-03-31	$726,977	38,669	+7.8%	Shares	Sole	2024-04-15
2023-12-31	$517,230	35,869	+20.5%	Shares	Sole	2024-01-30
2023-09-30	$516,807	29,770	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.